Subcutaneous administration of loxapine.
Sauder
C
C
Vancouver General Hospital, British Columbia, Canada.
Porterfield
P
P
Shalansky
K F
KF
Tong
K L
KL
D000328:Adult; D000368:Aged; D014150:Antipsychotic Agents / Q000008:administration & dosage*; D006801:Humans; D007273:Injections, Intramuscular; D007279:Injections, Subcutaneous; D008152:Loxapine / Q000008:administration & dosage* / Q000009:adverse effects; D008875:Middle Aged; D010166:Palliative Care / Q000379:methods
D014150:Antipsychotic Agents; D008152:Loxapine